<VariationArchive VariationID="627085" VariationName="NM_000552.5(VWF):c.50dup (p.Leu17fs)" VariationType="Duplication" Accession="VCV000627085" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2019-09-29" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="615519" VariationID="627085">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-" />
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.50dup (p.Leu17fs)</Name>
      <CanonicalSPDI>NC_000012.12:6123146:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6123146" stop="6123147" display_start="6123146" display_stop="6123147" variantLength="1" positionVCF="6123146" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6232312" stop="6232313" display_start="6232312" display_stop="6232313" variantLength="1" positionVCF="6232312" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>L17fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6232316dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6232316dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6123150dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6123150dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.6524dup">
            <Expression>NG_009072.2:g.6524dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.50dup" MANESelect="true">
            <Expression>NM_000552.5:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000543.3" sequenceAccession="NP_000543" sequenceVersion="3" change="p.Leu17fs">
            <Expression>NP_000543.3:p.Leu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.6524dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_587p1" sequenceAccession="LRG_587p1" change="p.Leu17fs">
            <Expression>LRG_587p1:p.Leu17fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.3" sequenceAccession="NM_000552" sequenceVersion="3" change="c.50dupT">
            <Expression>NM_000552.3:c.50dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.4" sequenceAccession="NM_000552" sequenceVersion="4" change="c.50dup">
            <Expression>NM_000552.4:c.50dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.50dupT" MANESelect="true">
            <Expression>NM_000552.5:c.50dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="751286556" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.50dup (p.Leu17fs) AND Hereditary von Willebrand disease" Accession="RCV000851810" Version="1">
        <ClassifiedConditionList TraitSetID="8941">
          <ClassifiedCondition DB="MedGen" ID="C5703318">Hereditary von Willebrand disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.50dup (p.Leu17fs) AND not provided" Accession="RCV003489860" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.50dup (p.Leu17fs) AND VWF-related disorder" Accession="RCV004549841" Version="1">
        <ClassifiedConditionList TraitSetID="87353">
          <ClassifiedCondition>VWF-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.50dup (p.Leu17fs) AND von Willebrand disorder" Accession="RCV004586919" Version="1">
        <ClassifiedConditionList TraitSetID="96512">
          <ClassifiedCondition DB="MedGen" ID="C0042974">von Willebrand disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-04-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-18" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-09-29" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33556167</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="87353" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68898" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VWF-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">VWF-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWF-related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8941" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary von Willebrand disease</ElementValue>
                <XRef ID="MONDO:0019565" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7867" />
                <XRef ID="7867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal recessive or Autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C5703318" DB="MedGen" />
              <XRef ID="D014842" DB="MeSH" />
              <XRef ID="MONDO:0019565" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="96512" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="47972" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">von Willebrand disorder</ElementValue>
                <XRef ID="128105004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">von Willebrand Diseases</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease (hereditary or acquired)</ElementValue>
                <XRef ID="MONDO:0024574" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">von Willebrand's disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD</ElementValue>
                <XRef ID="GTR000330731" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <XRef ID="C0042974" DB="MedGen" />
              <XRef ID="MONDO:0024574" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1769340" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.50dupT_C0042974" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899778" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0020</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.50dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">von Willebrand disorder</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0042974" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7914557" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="f9d6ce41c89ef7931ad332e6a72451dfe3cdf7f1fed02604ead9d2eb0cb89f2f|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004238397" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.4:c.50dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7683135" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="19510672|VWF-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004107052" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The VWF c.50dupT variant is predicted to result in a frameshift and premature protein termination (p.Leu17Phefs*25). This variant has been reported in individuals with VWF-related diseases (Downes et al. 2019. PubMed ID: 31064749. Suppl3_SNV+INDEL; Sadler et al. 2021. PubMed ID: 33556167. Table S2). This variant is reported in 0.0031% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in VWF are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.4:c.50dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VWF-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9856525" SubmissionDate="2024-07-09" DateLastUpdated="2024-07-15" DateCreated="2024-07-15">
        <ClinVarSubmissionID localKey="NM_000552.5:c.50dupT|MedGen:C0042974" />
        <ClinVarAccession Accession="SCV005077602" DateUpdated="2024-07-15" DateCreated="2024-07-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31064749</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33556167</ID>
          </Citation>
          <Comment>Variant summary: VWF c.50dupT (p.Leu17PhefsX25) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 8e-06 in 251454 control chromosomes. c.50dupT has been reported in the literature in individuals affected with VWF-related diseases and at-least one of these individuals were reported as heterozygous for this variant (example: Sadler_2021, Downes_2019). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31064749, 33556167). ClinVar contains an entry for this variant (Variation ID: 627085). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.5:c.50dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0042974" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-04.revised.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7914557" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7683135" TraitType="Disease" MappingType="Name" MappingValue="VWF-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="VWF-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769340" TraitType="Disease" MappingType="Name" MappingValue="von Willebrand disorder" MappingRef="Preferred">
        <MedGen CUI="C0042974" Name="von Willebrand disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9856525" TraitType="Disease" MappingType="XRef" MappingValue="C0042974" MappingRef="MedGen">
        <MedGen CUI="C0042974" Name="von Willebrand disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

